St. Louis-based Washington University School of Medicine researchers found that fidaxomicin, a treatment for Clostridioides difficile infection, has increased in use but “remains underutilized.” The ...

Recurrent C. diff infection is when you contract a C. diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while reinfection ...

At the end of 2010, Ellis Hospital noticed a troubling spike in Clostridium difficile infections. Clostridium difficile, or C-diff, is a common cause of diarrhea acquired in healthcare settings; it ...

Clostridium difficile infection recurrence may increase the risk of death in patients, according to a presentation at the 27th European Congress of Clinical Microbiology and Infectious Diseases, held ...

Antibiotics prescribed by dentists may contribute to the growing problem of Clostridium difficile (C. diff), a serious and potentially deadly infection that causes severe diarrhea, suggests research ...

Newly discovered iron storage 'ferrosomes' inside the bacterium C. diff -- the leading cause of hospital-acquired infections -- are important for infection in an animal model and could offer new ...

VA study finds a 45% reduction in Clostridioides difficile infections among high-risk patients with the use of doxycycline instead of azithromycin For patients who are admitted to a hospital with ...

One of the most common health care-associated infections spreads within intensive care units (ICUs) more than three times more than previously thought, new research has found. IMPACT: The results ...

Iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — could offer new targets for antibacterial drugs to combat the pathogen. A team of Vanderbilt ...